SEC Form 4 · accession 0001493152-17-009541
Rennova Health, Inc. · RNVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Aug 15, 2017
Accepted (ET)
Aug 17, 2017 · 3:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000931059
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted StockF1 | Aug 15, 2017 | A | 200,000 | $0.00 | A | 200,000 | D | |
| Common Stock | holding | — | — | — | 1,475 | D | ||
| Common Stock | holding | — | — | — | 64,231 | I | By: Alcimede LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The grant of restricted stock of Rennova Health, Inc. (the "Company") vests in full on August 15, 2018, subject to the reporting person's continuing to be a director of the Company.
Remarks
Exhibit List - Exhibit 99 - Joint Filer Information